Our study showed high expression of p16 cytoplasmic staining to be predictive of a better response to induction chemotherapy and was an independent prognostic factor for better PFS and OS when the status was HPV- HNSCC. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.